IN A NUTSHELLWhat if a drug that targets the process of aging could help us live longer, higher quality lives?
Israeli internist Nir Barzilai has worked with a diversity of populations–from the Israeli Army, to a Cambodian refugee camp, to a Zulu village. Perhaps his most fascinating patient population is 600 centenarians, whom he has studied to understand the biology and genetics of exceptional longevity. With this knowledge, Nir has spearheaded a randomized controlled trial of a medicine that interferes with the aging process to see if he can extend both the quantity and quality of life. With over 200 peer-reviewed papers and many national awards, Nir currently serves as Director of the Institute for Aging Research at Albert Einstein College of Medicine and is also Director of the NIH’s Nathan Shock and the Glenn Centers of Excellence in the Basic Biology of Aging.
LEARN MOREMetformin as a Tool to Target Aging
Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Cell Metabolism. 2016;23:1016-1065.
Live Long, Die Young
ABC Catalyst. June 2016.
What do centenarians know that the rest of us don’t?
Weintraub K. National Geographic. 2015.
Researchers study 3 promising anti-aging therapies
Weintraub K. Scientific American. 2015.
Anti-aging pill pushed as a bona fide drug
Hayden EC. Nature. 2015.
Does a real anti-aging pill already exist?
Gifford B. Bloomberg. 2015.
The Diabetes Drug That Could Be An Anti-Aging Miracle
Fleck A. Newsweek. 2015.
Science (and Quacks) vs. the Aging Process
Samuelson T. NY Times. 2014.
What Do a Bunch of Old Jews Know About Living Forever?
Green J. New York News & Politics. 2011.